Drs. Daniel Chao and Yoshihiro Yonekawa join for a preview of the November 2020 edition of Retinal Physician. Topics discussed include gene therapy applications for angiogenesis, pediatric retinal disease pearls, how to manage corneal surface issues after intravitreal injection and a common mimicker of choroidal melanoma.
Relevant Financial Disclosures: Dr. Sridhar is a consultant for Alcon, Dorc, Oxurion and Regeneron. Dr. Chao is a consultant for Genentech and receives research funding from Genentech and Bayer. Dr. Yonekawa is a consultant for Alcon and Allergan.
CME Information
Release: November 2, 2020; expires November 2, 2023
Reviewers: Purnima Patel, MD; Shriji Patel, MD; Carl Danzig, MD
Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.
Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.
Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.
Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.